EA201170368A1 - ANTI-MICROBIAL COMPOSITION - Google Patents

ANTI-MICROBIAL COMPOSITION

Info

Publication number
EA201170368A1
EA201170368A1 EA201170368A EA201170368A EA201170368A1 EA 201170368 A1 EA201170368 A1 EA 201170368A1 EA 201170368 A EA201170368 A EA 201170368A EA 201170368 A EA201170368 A EA 201170368A EA 201170368 A1 EA201170368 A1 EA 201170368A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
composition
pharmaceutically acceptable
diseases
fluoroquinolone
Prior art date
Application number
EA201170368A
Other languages
Russian (ru)
Other versions
EA019978B1 (en
Inventor
Анатолий Альбертович Кузьмин
Александр Николаевич Боровко
Original Assignee
Анатолий Альбертович Кузьмин
Александр Николаевич Боровко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анатолий Альбертович Кузьмин, Александр Николаевич Боровко filed Critical Анатолий Альбертович Кузьмин
Publication of EA201170368A1 publication Critical patent/EA201170368A1/en
Publication of EA019978B1 publication Critical patent/EA019978B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к ветеринарной медицине, в частности к препаратам, предназначенным для профилактики и лечения заболеваний, вызванных грамположительными и грамотрицательными микроорганизмами, простейшими, например возбудителями сальмонеллеза, колибактериоза, пастереллеза, микоплазмоза и других заболеваний. Противомикробная композиция содержит триметоприм, и/или по меньшей мере один фторхинолон, или по меньшей мере одну фармацевтически приемлемую соль фторхинолона, по меньшей мере одну органическую кислоту, вспомогательные вещества и фармацевтически приемлемый растворитель, при этом дополнительно содержит по меньшей мере один макролидный антибиотик или по меньшей мере одну фармацевтически приемлемую соль макролидного антибиотика. Таким образом, заявляемое изобретение представляет собой противомикробную композицию, которая благодаря своему качественному и количественному составу обладает высокой терапевтической эффективностью при лечении смешанных инфекционных заболеваний. Также применение композиции по данному изобретению обеспечивает большую эффективность, простоту обработки субъектов, подвергающихся лечению, является экономически целесообразным и безопасным за счет снижения вероятности побочного эффекта компонентов композиции.The invention relates to veterinary medicine, in particular to drugs intended for the prevention and treatment of diseases caused by gram-positive and gram-negative microorganisms, protozoa, such as pathogens of salmonellosis, colibacteriosis, pasteurellosis, mycoplasmosis and other diseases. The antimicrobial composition contains trimethoprim, and / or at least one fluoroquinolone, or at least one pharmaceutically acceptable fluoroquinolone salt, at least one organic acid, excipients and a pharmaceutically acceptable solvent, and additionally contains at least one macrolide antibiotic or at least one pharmaceutically acceptable salt of a macrolide antibiotic. Thus, the claimed invention is an antimicrobial composition, which due to its qualitative and quantitative composition has a high therapeutic efficacy in the treatment of mixed infectious diseases. Also, the use of the composition according to this invention provides greater efficiency, ease of treatment of subjects undergoing treatment, is economically feasible and safe by reducing the likelihood of side effects of the components of the composition.

EA201170368A 2010-01-29 2010-04-14 Antimicrobial composition EA019978B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UAA201000872A UA94177C2 (en) 2010-01-29 2010-01-29 antimicrobial composition
PCT/IB2010/051613 WO2011092551A1 (en) 2010-01-29 2010-04-14 Antimicrobial composition

Publications (2)

Publication Number Publication Date
EA201170368A1 true EA201170368A1 (en) 2012-01-30
EA019978B1 EA019978B1 (en) 2014-07-30

Family

ID=44318719

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170368A EA019978B1 (en) 2010-01-29 2010-04-14 Antimicrobial composition

Country Status (3)

Country Link
EA (1) EA019978B1 (en)
UA (1) UA94177C2 (en)
WO (1) WO2011092551A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA108238C2 (en) * 2012-12-24 2015-04-10 ANTIBACTERIAL COMPOSITION
CN117598997A (en) * 2023-08-21 2024-02-27 沈阳伟嘉生物技术有限公司 Tilmicosin-natural plant organic acid microcrystalline double salt powder preparation and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
UA46335U (en) * 2009-10-21 2009-12-10 Анатолій Альбертович Кузьмін Antibacterial composition

Also Published As

Publication number Publication date
WO2011092551A1 (en) 2011-08-04
EA019978B1 (en) 2014-07-30
UA94177C2 (en) 2011-04-11

Similar Documents

Publication Publication Date Title
NZ751197A (en) Compounds and methods of treating infections
BR112015003188A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT
BR112015027699A2 (en) USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
BR112015009168A2 (en) compound of formula xi, use of a compound, pharmaceutical composition, method of treating a pde4-mediated disease in a subject, method of modulating a pde4-mediated function in a subject, method of achieving an effect in a patient, and method to inhibit pde4
EA201390626A1 (en) DERIVATIVES OF HYDROXAMIC ACID AND APPLICATION OF INDICATED DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS
BR112015014458A2 (en) mannose derivatives for the treatment of bacterial infections
EA201692506A2 (en) ANTI-FLY VIRUS REPLICATION INHIBITORS
MX359989B (en) Antiviral drugs for treatment of arenavirus infection.
EA201100613A1 (en) CONDENSED, SPYROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EA201170689A1 (en) ANTI-MICROBIAL COMPOSITIONS
MX340985B (en) N-heteroaryl compounds.
EA201590697A1 (en) DERIVATIVES OF KETAMINE
NZ596628A (en) Ketolide compounds having antimicrobial activity
BR112019018615A2 (en) antimicrobial compounds, compositions and uses thereof
MX2015012472A (en) Mannose derivatives for treating bacterial infections.
MY186959A (en) New effective aminoglycoside antibiotic for multidrug-resistant bacteria
EA201170368A1 (en) ANTI-MICROBIAL COMPOSITION
MX357352B (en) Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment.
ECSP088132A (en) INHIBITORS OF 6-ALQUILIDENO-PENEME B-LACTAMASA BICYCLES AND ANTIBIOTIC COMBINATION OF ß-LACTAMA: A SPECTRO ANTIBIOTIC
CL2009000470A1 (en) Substituted 6-oxo-2,3-dihydro-6h-1-oxa-3,3a-diaza-phenalene derivative compounds; procedure for preparing the compounds; pharmaceutical composition; and its use in the treatment of bacterial infections, particularly useful against gram (+) and gram (-) bacteria, such as streptococcus, staphilococcus and escherichia coli, among others.
WO2014145713A3 (en) Aminoglycoside antibiotics with reduced ototoxicity
EA201400830A1 (en) ANTIBACTERIAL PHARMACEUTICAL COMPOSITION
EA200970881A1 (en) ANTIBACTERIAL COMPOSITION
EA201590351A1 (en) PEPTIDE COMBINATIONS WITH A CYCLIZED MAIN CHAIN

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM